NBC
PFE icon

Neuberger Berman Canada’s Pfizer PFE Stock Holding History

Neuberger Berman Canada’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-41,511
Closed -$1.28M – 330
2016
Q4 		$1.28M Buy
+41,511
New +$1.27M 0.32% 60

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Neuberger Berman Canada's PFE Position: Q3 2017 in Review

Neuberger Berman Canada increased its Pfizer (PFE) stake by 5.2% in Q3 2017, buying an estimated $675K and bringing the position to 427,789 shares worth $14.5M. The position accounts for 2.67% of the portfolio, ranked #2.

Neuberger Berman Canada first reported a position in PFE in Q3 2013 and has held it in 15 quarters since. 2,040 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • Neuberger Berman Canada held 427,789 shares of Pfizer worth $14.5M as of Q3 2017.
  • Neuberger Berman Canada bought 21,011 Pfizer shares in Q3 2017, an estimated $675K.
  • Pfizer made up 2.67% of Neuberger Berman Canada's portfolio in Q3 2017, its #2 holding.
  • Neuberger Berman Canada first reported a position in Pfizer in Q3 2013 and has held it in 15 quarters since.
  • 2,040 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Neuberger Berman Canada's 13F filing for Q3 2017, filed 3 Nov 2017.